VivoSim Labs, Inc. is engaged in the development of bioprinted human tissues that emulate human biology and disease. Its three-dimensional human tissue platform is enabled by its proprietary NovoGen Bioprinters and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company was founded on January 30, 2012 and is headquartered in San Diego, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
15
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. VivoSim Labs Inc. market cap is $5.29M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. VivoSim Labs Inc. 52 week high is $3.40 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. VivoSim Labs Inc. 52 week low is $0.118 as of November 22, 2026.
VivoSim Labs Inc. stock price today is $0.2608.
VivoSim Labs Inc. stock price yesterday was $0.2915.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. VivoSim Labs Inc.'s P/E ratio is -0.07.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. VivoSim Labs Inc. P/B ratio is 0.6506.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. VivoSim Labs Inc. 50-day moving average is $0.1842.